Maca (Lepidium meyenii) for Energy, Mood, and Sexual Desire
Maca is not recommended for improving energy, mood, or sexual desire in healthy adults based on current clinical practice guidelines, which explicitly state that herbal therapies lack sufficient evidence from rigorous trials and should not be used for sexual dysfunction. 1
Guideline-Based Position
The American Urological Association (AUA) and American Association of Clinical Endocrinologists provide clear guidance on herbal therapies:
Herbal therapies are not recommended for treatment of erectile dysfunction or sexual dysfunction due to insufficient documentation of mechanisms, effectiveness, and safety in repeated, randomized controlled trials with independent monitoring 1
Critical safety concerns exist: Lack of regulation permits disparities in raw materials, manufacturing variations, inconsistent product potency within and between brands, and documented contamination of some herbal products with therapeutic levels of PDE5 inhibitors 1
The guidelines emphasize that despite worldwide use, the absence of rigorous clinical validation prevents any recommendation for herbal therapies in sexual health 1
Research Evidence (Limited and Conflicting)
While guidelines advise against use, research studies show mixed results:
Potential Benefits (from small trials):
- A systematic review identified only 4 RCTs meeting inclusion criteria, with limited evidence suggesting possible improvements in sexual desire in healthy men and menopausal women 2
- One small trial (n=50) in men with mild ED showed modest IIEF-5 score improvement of 1.6 points versus 0.5 with placebo after 12 weeks at 2400 mg daily 3
- Sexual desire improvement observed at 8 weeks with 1500-3000 mg daily, independent of testosterone levels 4
- Effects on energy and mood reported but not consistently demonstrated across studies 5, 6
Critical Limitations:
- Total number of trials, sample sizes, and methodological quality too limited to draw firm conclusions 2
- No standardized dosing protocols established
- Mechanisms of action remain unclear 5
- Different maca phenotypes (yellow, black, red) may have different effects 5
Dosing (If Used Despite Guidelines)
Research studies used:
- 1500-3000 mg daily for sexual desire 4
- 2400 mg daily for mild ED 3
- Treatment duration: 8-12 weeks minimum before effects observed 4, 3
Safety Profile
- No serious adverse events reported in clinical trials 2, 3
- Serum testosterone, estradiol, LH, FSH, and prolactin levels not affected 4
- Long-term safety data lacking
- Major concern: Product quality and contamination risk due to lack of regulation 1
Contraindications
No specific contraindications established in literature, but:
- Avoid in hormone-sensitive conditions (theoretical concern given traditional use)
- Exercise caution with unregulated supplements due to contamination risk
- Not studied in pregnant/lactating women
Clinical Recommendation Algorithm
For patients inquiring about maca:
First-line approach: Explain that clinical practice guidelines do not support herbal therapy use due to insufficient evidence and safety concerns 1
If sexual dysfunction present: Offer evidence-based treatments:
If patient insists on trying maca: Counsel on:
- Lack of regulatory oversight and contamination risk
- Inconsistent product quality
- Need for 8-12 week trial period
- Expected modest effects at best
- Importance of purchasing from reputable sources with third-party testing
Monitor: Reassess at 8-12 weeks; if no benefit, discontinue and pursue evidence-based alternatives
Common Pitfalls to Avoid
- Do not recommend maca as first-line therapy for any indication related to energy, mood, or sexual function
- Do not assume product purity: Contamination with PDE5 inhibitors has been documented 1
- Do not extrapolate animal data: Effects in rats do not reliably predict human outcomes
- Do not ignore underlying medical conditions: Sexual dysfunction often signals cardiovascular disease, diabetes, or hormonal disorders requiring proper evaluation 10
The evidence hierarchy clearly prioritizes guideline recommendations against herbal therapies over limited positive research findings, particularly given safety concerns about product quality and contamination.